Karyopharm to Participate at Upcoming Investor Conferences

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

Related Keywords

London ,City Of ,United Kingdom ,China ,Piper Sandler ,Prnewswire Karyopharm Therapeutics Inc ,Selective Inhibitor Of Nuclear Export ,Karyopharm Therapeutics Inc ,Linkedin ,Nasdaq ,Annual Healthcare ,Selective Inhibitor ,Nuclear Export ,